Cost-effectiveness analysis of community-acquired pneumonia therapeutic treatments
-
摘要: 目的 评价两种治疗方案对治疗社区获得性肺炎的药物经济学效果,指导合理用药。 方法 对两种治疗方案运用成本-效果分析法进行分析。 结果 两种治疗方案中,单用莫西沙星(A组)总成本为4 092.75元,联合使用阿奇霉素和头孢呋辛(B组)总成本为3 306.83元;有效率分别为88.89%和85.71%;单位效果的增量成本分别为46.04元和38.58元。 结论 联合使用阿奇霉素和头孢呋辛治疗社区获得性肺炎更为经济合理。Abstract: Objective To evaluate the pharmacoeconomics effectiveness of two community-acquired pneumonia therapeutic treatments, and provide guidance for rational drug use. Methods Two therapeutic schemes were analyzed through cost-effectiveness analysis.Result Between the two treatments, the total cost by using moxifloxacin alone (Group A) was 4 092.75 RMB, while that of using azithromycin and cefuroxime (Group B) combined was 3 306.83 RMB; the effective rates were 88.89% and 85.71%, respectively; the incremental cost for each effect unit of these two treatments was 46.04 RMB and 38.58 RMB. Conclusion It is more economical and reasonable to use azithromycin and cefuroxime combination for the therapeutic treatment of community-acquired pneumonia.
-
[1] 吴袁剑云,英立平.临床路径实施手册[M].北京:北京医科大学出版社,2002:8. [2] 中华医学会呼吸病学分会.社区获得性肺炎诊断和治疗指南2006版[S].2006:5. [3] 中华人民共和国卫生部药政司.抗菌药物临床研究指导原则[S].北京:中华人民共和国卫生部,1993:2. [4] 丁玉峰,吴方建.药物经济学理论及应用[J].中国药师,2004,7(7):507-510. [5] 周玉清.三种胃溃疡伴幽门螺旋菌感染治疗方案的成本-效果分析[J].海峡药学,2003,15(2):73-74. -
![WeChat](/fileYXSJZZ/journal/article/yxsjzz/2014/4/PIC/wechat_cn_20140423.jpg)
计量
- 文章访问数: 2244
- HTML全文浏览量: 252
- PDF下载量: 79
- 被引次数: 0